The Ministry of Health, Labor and Welfare has entered into final adjustments on the 20th of this month to simultaneously decide whether or not to approve the vaccines of the two new coronavirus vaccines for which approval applications have been submitted.
In Japan, following Pfizer, the UK AstraZeneca vaccine was submitted for approval in February, and the American Moderna vaccine was submitted for approval in March.
The Ministry of Health, Labor and Welfare is currently conducting a review of efficacy and safety based on data from overseas clinical trials.
According to the people concerned, the Ministry of Health, Labor and Welfare has entered into final adjustments to decide whether or not to approve the vaccines of the two companies at the same time by holding a subcommittee made up of experts on the 20th of this month.
The contract with Moderna is to supply 25 million people by September, and the government will use it at large inoculation centers in Tokyo and Osaka, which it aims to open on the 24th of this month. I am considering.
In addition, although it has been pointed out that the AstraZeneca vaccine, which has a supply contract for 60 million people, has a risk of blood clots in extremely rare cases, it is said that the effect exceeds the risk and the vaccine is continued with age restrictions. In some countries, the expert group is expected to consider how to deal with it.